Equities

BetterLife Pharma Inc

BetterLife Pharma Inc

Actions
  • Price (EUR)0.125
  • Today's Change-0.001 / -0.79%
  • Shares traded1.00k
  • 1 Year change-55.55%
  • Beta--
Data delayed at least 15 minutes, as of May 29 2020 07:22 BST.
More ▼

Profile data is unavailable for this security.

About the company

BetterLife Pharma Inc., formerly Pivot Pharmaceuticals Inc., is a biopharmaceutical company. The Company is engaged in the development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. The Company delivers and commercializes cannabinoid, cannabidiol and tetrahydrocannabinol-based products. The Company’s technologies include ready to infuse cannabis (RTIC), BiPhasix, Thrudermic and Solmic.

  • Revenue in CAD (TTM)--
  • Net income in CAD--
  • Incorporated2002
  • Employees0.00
  • Location
    BetterLife Pharma Inc1275 WEST 6TH AVENUEVANCOUVER V6H 1A6CanadaCAN
  • Phone+1 43 8884 8841
  • Fax+1 60 4551 5178
  • Websitehttps://pivotpharma.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
since
announced
Transaction
value
SolMic AGAnnounced03 Feb 202003 Feb 2020Announced42.86%--
Data delayed at least 15 minutes, as of May 29 2020.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.